Evaluation of Luminogenic Substrates as Probe Substrates for Bacterial Cytochrome P450 Enzymes: Application to Mycobacterium tuberculosis

Sandra Ortega Ugalde, Dongping Ma, James J. Cali, Jan N.M. Commandeur

Research output: Contribution to JournalArticleAcademicpeer-review

Abstract

Several cytochrome P450 enzymes (CYPs) encoded in the genome of Mycobacterium tuberculosis (Mtb) are considered potential new drug targets due to the essential roles they play in bacterial viability and in the establishment of chronic intracellular infection. Identification of inhibitors of Mtb CYPs at present is conducted by ultraviolet-visible (UV-vis) optical titration experiments or by metabolism studies using endogenous substrates, such as cholesterol and lanosterol. The first technique requires high enzyme concentrations and volumes, while analysis of steroid hydroxylation is dependent on low-throughput analytical methods. Luciferin-based luminogenic substrates have proven to be very sensitive substrates for the high-throughput profiling of inhibitors of human CYPs. In the present study, 17 pro-luciferins were evaluated as substrates for Mtb CYP121A1, CYP124A1, CYP125A1, CYP130A1, and CYP142A1. Luciferin-BE was identified as an excellent probe substrate for CYP130A1, resulting in a high luminescence yield after addition of luciferase and adenosine triphosphate (ATP). Its applicability for high-throughput screening was supported by a high Z’-factor and high signal-to-background ratio. Using this substrate, the inhibitory properties of a selection of known inhibitors could be characterized using significantly less protein concentration when compared to UV-vis optical titration experiments. Although several luminogenic substrates were also identified for CYP121A1, CYP124A1, CYP125A1, and CYP142A1, their relatively low yield of luminescence and low signal-to-background ratios make them less suitable for high-throughput screening since high enzyme concentrations will be needed. Further structural optimization of luminogenic substrates will be necessary to obtain more sensitive probe substrates for these Mtb CYPs.

Original languageEnglish
Pages (from-to)745-754
Number of pages10
JournalSLAS Discovery
Volume24
Issue number7
Early online date17 Jun 2019
DOIs
Publication statusPublished - 1 Aug 2019

Fingerprint

Mycobacterium tuberculosis
Cytochrome P-450 Enzyme System
Substrates
Luminescence
Lanosterol
Microbial Viability
Throughput
Enzymes
Hydroxylation
Luciferases
Titration
Adenosine Triphosphate
Steroids
Cholesterol
Screening
Genome
Structural optimization
Infection
Pharmaceutical Preparations
Metabolism

Keywords

  • bioluminescence
  • cytochrome P450
  • high-throughput screening
  • Mycobacterium tuberculosis
  • tuberculosis

Cite this

@article{3a396b2171a14577a0d15b6372fba601,
title = "Evaluation of Luminogenic Substrates as Probe Substrates for Bacterial Cytochrome P450 Enzymes: Application to Mycobacterium tuberculosis",
abstract = "Several cytochrome P450 enzymes (CYPs) encoded in the genome of Mycobacterium tuberculosis (Mtb) are considered potential new drug targets due to the essential roles they play in bacterial viability and in the establishment of chronic intracellular infection. Identification of inhibitors of Mtb CYPs at present is conducted by ultraviolet-visible (UV-vis) optical titration experiments or by metabolism studies using endogenous substrates, such as cholesterol and lanosterol. The first technique requires high enzyme concentrations and volumes, while analysis of steroid hydroxylation is dependent on low-throughput analytical methods. Luciferin-based luminogenic substrates have proven to be very sensitive substrates for the high-throughput profiling of inhibitors of human CYPs. In the present study, 17 pro-luciferins were evaluated as substrates for Mtb CYP121A1, CYP124A1, CYP125A1, CYP130A1, and CYP142A1. Luciferin-BE was identified as an excellent probe substrate for CYP130A1, resulting in a high luminescence yield after addition of luciferase and adenosine triphosphate (ATP). Its applicability for high-throughput screening was supported by a high Z’-factor and high signal-to-background ratio. Using this substrate, the inhibitory properties of a selection of known inhibitors could be characterized using significantly less protein concentration when compared to UV-vis optical titration experiments. Although several luminogenic substrates were also identified for CYP121A1, CYP124A1, CYP125A1, and CYP142A1, their relatively low yield of luminescence and low signal-to-background ratios make them less suitable for high-throughput screening since high enzyme concentrations will be needed. Further structural optimization of luminogenic substrates will be necessary to obtain more sensitive probe substrates for these Mtb CYPs.",
keywords = "bioluminescence, cytochrome P450, high-throughput screening, Mycobacterium tuberculosis, tuberculosis",
author = "{Ortega Ugalde}, Sandra and Dongping Ma and Cali, {James J.} and Commandeur, {Jan N.M.}",
year = "2019",
month = "8",
day = "1",
doi = "https://doi.org/10.1177/2472555219853220",
language = "English",
volume = "24",
pages = "745--754",
journal = "SLAS Discovery",
issn = "2472-5552",
publisher = "SAGE Publications Inc.",
number = "7",

}

Evaluation of Luminogenic Substrates as Probe Substrates for Bacterial Cytochrome P450 Enzymes : Application to Mycobacterium tuberculosis. / Ortega Ugalde, Sandra; Ma, Dongping; Cali, James J.; Commandeur, Jan N.M.

In: SLAS Discovery, Vol. 24, No. 7, 01.08.2019, p. 745-754.

Research output: Contribution to JournalArticleAcademicpeer-review

TY - JOUR

T1 - Evaluation of Luminogenic Substrates as Probe Substrates for Bacterial Cytochrome P450 Enzymes

T2 - Application to Mycobacterium tuberculosis

AU - Ortega Ugalde, Sandra

AU - Ma, Dongping

AU - Cali, James J.

AU - Commandeur, Jan N.M.

PY - 2019/8/1

Y1 - 2019/8/1

N2 - Several cytochrome P450 enzymes (CYPs) encoded in the genome of Mycobacterium tuberculosis (Mtb) are considered potential new drug targets due to the essential roles they play in bacterial viability and in the establishment of chronic intracellular infection. Identification of inhibitors of Mtb CYPs at present is conducted by ultraviolet-visible (UV-vis) optical titration experiments or by metabolism studies using endogenous substrates, such as cholesterol and lanosterol. The first technique requires high enzyme concentrations and volumes, while analysis of steroid hydroxylation is dependent on low-throughput analytical methods. Luciferin-based luminogenic substrates have proven to be very sensitive substrates for the high-throughput profiling of inhibitors of human CYPs. In the present study, 17 pro-luciferins were evaluated as substrates for Mtb CYP121A1, CYP124A1, CYP125A1, CYP130A1, and CYP142A1. Luciferin-BE was identified as an excellent probe substrate for CYP130A1, resulting in a high luminescence yield after addition of luciferase and adenosine triphosphate (ATP). Its applicability for high-throughput screening was supported by a high Z’-factor and high signal-to-background ratio. Using this substrate, the inhibitory properties of a selection of known inhibitors could be characterized using significantly less protein concentration when compared to UV-vis optical titration experiments. Although several luminogenic substrates were also identified for CYP121A1, CYP124A1, CYP125A1, and CYP142A1, their relatively low yield of luminescence and low signal-to-background ratios make them less suitable for high-throughput screening since high enzyme concentrations will be needed. Further structural optimization of luminogenic substrates will be necessary to obtain more sensitive probe substrates for these Mtb CYPs.

AB - Several cytochrome P450 enzymes (CYPs) encoded in the genome of Mycobacterium tuberculosis (Mtb) are considered potential new drug targets due to the essential roles they play in bacterial viability and in the establishment of chronic intracellular infection. Identification of inhibitors of Mtb CYPs at present is conducted by ultraviolet-visible (UV-vis) optical titration experiments or by metabolism studies using endogenous substrates, such as cholesterol and lanosterol. The first technique requires high enzyme concentrations and volumes, while analysis of steroid hydroxylation is dependent on low-throughput analytical methods. Luciferin-based luminogenic substrates have proven to be very sensitive substrates for the high-throughput profiling of inhibitors of human CYPs. In the present study, 17 pro-luciferins were evaluated as substrates for Mtb CYP121A1, CYP124A1, CYP125A1, CYP130A1, and CYP142A1. Luciferin-BE was identified as an excellent probe substrate for CYP130A1, resulting in a high luminescence yield after addition of luciferase and adenosine triphosphate (ATP). Its applicability for high-throughput screening was supported by a high Z’-factor and high signal-to-background ratio. Using this substrate, the inhibitory properties of a selection of known inhibitors could be characterized using significantly less protein concentration when compared to UV-vis optical titration experiments. Although several luminogenic substrates were also identified for CYP121A1, CYP124A1, CYP125A1, and CYP142A1, their relatively low yield of luminescence and low signal-to-background ratios make them less suitable for high-throughput screening since high enzyme concentrations will be needed. Further structural optimization of luminogenic substrates will be necessary to obtain more sensitive probe substrates for these Mtb CYPs.

KW - bioluminescence

KW - cytochrome P450

KW - high-throughput screening

KW - Mycobacterium tuberculosis

KW - tuberculosis

UR - http://www.scopus.com/inward/record.url?scp=85067839074&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85067839074&partnerID=8YFLogxK

U2 - https://doi.org/10.1177/2472555219853220

DO - https://doi.org/10.1177/2472555219853220

M3 - Article

VL - 24

SP - 745

EP - 754

JO - SLAS Discovery

JF - SLAS Discovery

SN - 2472-5552

IS - 7

ER -